Search for your favorite author
Steve
Amy
Natalie
Gary
this month featured authors
or click on the right to get a complete list of authors
Continue to the categorySubscribe! Newsletter This week's featured author
One article every two weeks from pharma experts
Editor´s Pick
U.S. overdose deaths post annual drop for first time in two decades
U.S. overdose deaths dropped last year for the first time in nearly two decades, the Centers for Disease Control and Prevention said on Wednesday, in a sign that a nationwide epidemic of drug-related deaths is abating. 
Paint makers reach $305 million settlement in California, ending marathon lead poisoning lawsuit
After a 19-year legal struggle, three former makers of lead paint have agreed to a $305 million settlement with California county and city governments to mitigate poisoning dangers still present in old housing. 
Merck’s treatment for urinary, abdominal infections gets FDA approval
The U.S. Food and Drug Administration has approved Merck & Co Inc's combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday. 
India’s Strides tried to shred quality-control documents: FDA
The U.S. Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd's quality-control practices after finding adulteration and evidence of "uncontrolled shredding of documents" at one of its plants. 
Abbott to hike production of lower-cost glucose monitors as diabetes soars
Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the next few years, aiming to reach millions more patients worldwide, the company told Reuters. 
Democrat Harris unveils plan to lower drug costs, put ‘people over profit’
Democratic presidential candidate Kamala Harris unveiled a plan on Tuesday to crack down on pharmaceutical companies which overcharge for prescription drugs, making her the latest 2020 White House candidate to seize on the issue. 
U.S. judge slashes Roundup jury award to $25.3 million; Bayer still plans to appeal
A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's bid for a new trial. 
Biden cancer group shuts down operations
The Biden Cancer Initiative, a non-profit organization started by former Vice President Joe Biden to support cancer prevention and research, said on Monday it suspended operations last week, two and a half months after Biden and his wife resigned from the group to focus on his presidential campaign. 
GSK drug helps ovarian cancer patients live longer in late-stage study
GlaxoSmithKline Plc's cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said on Monday. 
Oklahoma, J&J to wrap up first trial over opioid crisis
Oklahoma's attorney general is expected on Monday to urge a judge to find Johnson & Johnson responsible for flooding the market with painkillers and fueling the U.S. opioid epidemic, as the first trial in nationwide litigation over the drug crisis comes to an end. 
Biden healthcare plan would curb drug prices, raise taxes on rich
Former U.S. Vice President Joe Biden, the front-runner in the Democratic presidential race, unveiled a healthcare plan on Monday estimated to cost $750 billion and paid for partly by higher tax rates for the wealthy and doubled tax rates on capital gains. 
AstraZeneca’s Farxiga fails to get U.S. approval for Type-1 diabetes
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition. 
Look Who’s On the Move!
Research and Development
Regulatory Affairs
Industry News
